# A Study Using the LMC Diabetes Registry to Learn More About Chronic Kidney Disease (CKD) in Canadian Patients With Type 2 Diabetes (T2D)

> **NCT04445181** · — · COMPLETED · sponsor: **Bayer** · enrollment: 14873 (actual)

## Conditions studied

- Chronic Kidney Disease in Type 2 Diabetes

## Interventions

- **DRUG:** The physician's prescription in routine clinical practice

## Key facts

- **NCT ID:** NCT04445181
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-01
- **Primary completion:** 2020-11-23
- **Final completion:** 2020-11-23
- **Target enrollment:** 14873 (ACTUAL)
- **Last updated:** 2021-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04445181

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04445181, "A Study Using the LMC Diabetes Registry to Learn More About Chronic Kidney Disease (CKD) in Canadian Patients With Type 2 Diabetes (T2D)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04445181. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*